Blind man Ending Trachoma

Trachoma is an infectious disease responsible, at present, for approximately 3% of the world’s blindness.

On November 16th, PQMD member Pfizer, the International Trachoma Initiative, and the International Coalition for Trachoma Control announced the 500 millionth donated dose of Zithromax® Tablets. Zithromax® (azithromycin) is an antibiotic used to treat Trachoma, an infectious and debilitating disease which can ultimately lead to permanent blindness. This 500 millionth donation is an important mark in a determined global effort to eliminate Trachoma entirely by the year 2020.

2.2 million people are already affected by Trachoma, with about 1.2 million already made irreversibly blind by it. Currently, there are 232 million people still at risk for developing Trachoma in over 58 countries, with the highest risk amongst African countries – in particular Ethiopia, where 75 million people are still threatened by the disease.
In partnership with the World Health Organization’s Alliance for the Global Elimination of Trachoma by 2020, Pfizer’s 500 millionth donation is a crucial part of the 4 step strategy being enacted to reduce and eventually eradicate Trachoma. The landmark donation from Pfizer is part of the current efforts to end Ethiopia’s battle with the disease, where concentrated efforts are continuing.

You can read more about what Pfizer and the global community is doing to end Trachoma here.